Quick Takeaways
- Hudson Bay Capital Management LP filed SCHEDULE 13G/A for Psyence Biomedical Ltd. Common Shares, no par value (PBM).
- Disclosed ownership: 5%.
- Date of event: 31 Mar 2025.
Hudson Bay Capital Management LP - 31 Mar 2025 SCHEDULE 13G/A Report for Psyence Biomedical Ltd. Common Shares, no par value (PBM)
- Filing Manager
- Hudson Bay Capital Management LP
- Reporting Manager
- Hudson Bay Capital Management LP
- Symbol
- PBM
- Shares outstanding
- 4,764,890 shares
- Disclosed Ownership
- 237,768 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 May 2025, 15:52:32 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 10 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Hudson Bay Capital Management LP disclosed 5% ownership in Psyence Biomedical Ltd. Common Shares, no par value (PBM) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 10 Feb 2025.
- Current filing was accepted on 14 May 2025, 15:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 5% | 237,768 | 0 | 237,768 | /s/ Sander Gerber | Sander Gerber, Authorized Signatory | |
| Sander Gerber | 5% | 237,768 | 0 | 237,768 | /s/ Sander Gerber | Sander Gerber, Individually |